Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 16/20 | 0.67 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.67 |
| ▸ | CYP8B1 | Q9UNU6 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.67 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.67 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | FYN | P06241 | 2/20 | 0.45 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.45 |
| ▸ | TACR1 | P25103 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1723344 | 0.94 | CYP3A4 (0.69) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL1723625 | 0.93 | CYP3A4 (0.68) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL3334427 | 0.93 | CYP3A4 (0.64) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL3340498 | 0.93 | CYP3A4 (0.64) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL1687950 | 0.88 | CYP3A4 (0.84) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL13302816 | 0.87 | CYP3A4 (0.55) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL13302803 | 0.87 | CYP3A4 (0.55) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL1724025 | 0.87 | CYP3A4 (0.56) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL1723716 | 0.86 | CYP3A4 (0.62) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 | |
| SCHEMBL1723511 | 0.86 | CYP3A4 (0.57) | CYP3A4ABCG2ABCB11CYP8B1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2343980-A1 | TRIAZOLE ANTIFUNGAL AGENTS | Wu, Nian (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100143455-A1 | Triazole antifungal agents | WU NIAN | 2010-06-10 | — | — | US | disclosed |
| WO-2010027496-A1 | TRIAZOLE ANTIFUNGAL AGENTS | WU NIAN (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143455-A1 | Triazole antifungal agents | CYP3A7, ERG28, UGT1A7 | CYP3A4 33/4885ABCG2 25/4885ABCB11 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.